This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Zelgen Pharma.tech Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Liyun Gu and Her Patent Work in Biopharmaceutical Innovation.
Introduction
Liyun Gu is an inventor associated with Shanghai, China, whose patent work concerns antibody-based biotechnology. The provided information lists one patent in her name.
Latest Patents
Gu’s listed patent is “Anti-Human CD47 Antibody and Antigen-Binding Fragment Thereof, and Preparation Method Therefor and Use Thereof.” It addresses an antibody targeting human CD47, along with related antigen-binding fragments, preparation methods, and uses. The provided data records 1 patent and does not specify its filing or publication date.
Career Highlights
The supplied information associates Gu with Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Shanghai Zelgen Pharma.tech Co., Ltd. Her listed patent reflects work in antibody development and biopharmaceutical research.
Collaborations
Gu’s named coworkers include Yong Zhao and Shifu Mo. Their inclusion indicates professional connections in the context of her reported work, though the specific nature of their collaboration is not provided.
Conclusion
Liyun Gu’s recorded contribution is a patent focused on an anti-human CD47 antibody and its preparation and use, within a career associated with biopharmaceutical companies in China.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile